Towards prognostic biomarkers in pulmonary arterial hypertension

European Respiratory Journal

Volumn 39, Issue 4, 2012, Pages 799-801

  Cracowski, J L ^a,b  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b University Grenoble Alpes   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; TROPONIN I; TROPONIN T;

CLINICAL ASSESSMENT; CLINICAL PRACTICE; COST EFFECTIVENESS ANALYSIS; CYTOKINE PRODUCTION; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; EDITORIAL; HEART MUSCLE INJURY; HUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; REPRODUCIBILITY; RISK FACTOR; SENSITIVITY AND SPECIFICITY;

FEMALE; HUMANS; HYPERTENSION, PULMONARY; MALE; SEVERITY OF ILLNESS INDEX; TROPONIN I;

EID: 84860346494     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00155411     Document Type: Editorial

References (18)

1. Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 2001; 69: 89-95.
2. Poste G. Bring on the biomarkers. Nature 2011; 469: 156-157.
3. Benza RL, Miller DP, Gomberg-Maitland M, et al. Predicting survival in pulmonary arterial hypertension: insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management (REVEAL). Circulation 2011; 122: 164-172.
4. Soon E, Holmes AM, Treacy CM, et al. Elevated levels of inflammatory cytokines predict survival in idiopathic and familial pulmonary arterial hypertension. Circulation 2010; 122: 920-927.
5. Manolio T. Novel risk markers and clinical practice. N Engl J Med 2003; 349: 1587-1589. (Pubitemid 37288564)
6. Ware JH. The limitations of risk factors as prognostic tools. N Engl J Med 2006; 355: 2615-2617. (Pubitemid 44969120)
7. Torbicki A, Kurzyna M, Kuca P, et al. Detectable serum cardiac troponin T as a marker of poor prognosis among patients with chronic precapillary pulmonary hypertension. Circulation 2003; 108: 844-848. (Pubitemid 37022127)
8. Fijalkowska A, Kurzyna M, Torbicki A, et al. Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension. Chest 2006; 129: 1313-1321.
9. Heresi GA, Tang WHW, Aytekin M, et al. Sensitive cardiac troponin I predicts outcomes in pulmonary arterial hypertension. Eur Respir J 2012; 39: 939-944.
10. Giannitsis E, Katus HA. Comparison of cardiac troponin T and troponin I assays - implications of analytical and biochemical differences on clinical performance. Clin Lab 2004; 50: 521-528. (Pubitemid 39307361)
11. Christenson RH, Phillips D. Sensitive and high sensitivity next generation cardiac troponin assays: more than just a name. Pathology 2011; 43: 213-219.
12. Filusch A, Giannitsis E, Katus HA, et al. High-sensitive troponin T: a novel biomarker for prognosis and disease severity in patients with pulmonary arterial hypertension. Clin Sci (Lond) 2010; 119: 207-213.
13. Humbert M, Monti G, Brenot F, et al. Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension. Am J Respir Crit Care Med 1995; 151: 1628-1631.
14. Itoh T, Nagaya N, Ishibashi-Ueda H, et al. Increased plasma monocyte chemoattractant protein-1 level in idiopathic pulmonary arterial hypertension. Respirology 2006; 11: 158-163. (Pubitemid 43356895)
15. Lorenzen JM, Nickel N, Kramer R, et al. Osteopontin in patients with idiopathic pulmonary hypertension. Chest 2011; 139: 1010-1017.
16. Quarck R, Nawrot T, Meyns B, et al. C-reactive protein: a new predictor of adverse outcome in pulmonary arterial hypertension. J Am Coll Cardiol 2009; 53: 1211-1218.
17. Abdul-Salam VB, Paul GA, Ali JO, et al. Identification of plasma protein biomarkers associated with idiopathic pulmonary arterial hypertension. Proteomics 2006; 6: 2286-2294.
18. Meyrick BO, Friedman DB, Billheimer DD, et al. Proteomics of transformed lymphocytes from a family with familial pulmonary arterial hypertension. Am J Respir Crit Care Med 2008; 177: 99-107.